Acellular vaccines and resurgence of pertussis

JAMA

Volumn 308, Issue 20, 2012, Pages 2149-2150

  Shapiro, Eugene D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

ACTIVE IMMUNIZATION; CAUSAL ATTRIBUTION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; INFECTION PREVENTION; OUTCOME ASSESSMENT; PERTUSSIS; PRIORITY JOURNAL;

EID: 84869856022     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.65031     Document Type: Editorial

References (14)

1. Cherry JD. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med. 2012;367(9):785-787.
2. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 Years - United States, 2012 [published correction appears in MMWR Morb Mortal Wkly Rep. 2012;61(8):147]. MMWR Morb Mortal Wkly Rep. 2012;61(5):1-4.
3. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(1):13-15.
4. Centers for Disease Control and Prevention. Pertussis epidemic - Washington, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(28):517-522.
5. Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics. 2005;115(5):1422-1427. (Pubitemid 43852794)
6. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010 [published online July 20, 2012]. J Pediatr. doi:10.1016/j.peds.2012.05. 041.
7. Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308(20):2126-2132.
8. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367(11):1012-1019.
9. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54(12):1730-1735.
10. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev. 1988;10:212-241. (Pubitemid 18262846)
11. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA. 2012;308(5):454-456.
12. Cherry JD. Why do pertussis vaccines fail? Pediatrics. 2012;129(5):968-970.
13. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(41):1424-1426.
14. Dworkin MS. Adults are whooping, but are internists listening? Ann Intern Med. 2005;142(10):832-835. (Pubitemid 40664042)